Bacterial endocarditis is a serious and potentially life-threatening infection of the inner lining of the heart chambers (endocardium) or heart valves. It occurs when bacteria enter the bloodstream and attach to damaged areas of the heart, forming infective masses known as vegetations. Common causative bacteria include Streptococcus and Staphylococcus species. Individuals with pre-existing heart conditions, such as damaged heart valves or congenital heart defects, are at an increased risk of developing bacterial endocarditis. The condition often presents with symptoms like fever, fatigue, chills, and heart murmurs. Diagnosis involves blood cultures and imaging studies like echocardiography. Bacterial endocarditis requires prompt and targeted antibiotic treatment to eliminate the infecting bacteria. In severe cases or when complications arise, surgical intervention may be necessary to repair or replace damaged heart valves. Preventive measures involve antibiotic prophylaxis before certain dental or medical procedures in individuals with high-risk conditions. However, recommendations for prophylaxis have evolved, and the decision is often based on individual patient factors. Timely diagnosis and appropriate management are crucial to improving outcomes and reducing the risk of complications associated with bacterial endocarditis.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States